Surgery Websites
Transplant Surgery »  Meet the Team »  Hepatology »  Danielle Brandman, M.D., M.A.S.
Danielle Brandman, M.D., M.A.S.

Danielle Brandman, M.D., M.A.S.

Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 514-1094 - Phone
(415) 476-0659 - Fax
Danielle.Brandman@ucsf.edu
Open Popup

Boston University, B.A., Biology and Psychology, 1995-1999

UMDNJ-New Jersey Medical School, M.D., 2001-2005

University of California, San Francisco, M.A.S., Clinical Research, 2009-2011

  • University of California, San Francisco, Intern, Medicine, 2005-2006
  • University of California, San Francisco, Resident, Medicine, 2006-2008
  • University of California, San Francisco, Fellow, Gastroenterology, 2008-2011
  • University of California, San Francisco, Fellow, Transplant Hepatology, 2011-2012
  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology
  • UCSF Liver Center
  • Hepatitis C virus (HCV)
  • Liver injury and repair (Liver transplantation)
  • Nonalcoholic steatohepatitis (NASH)

Dr. Danielle Brandman is an Assistant Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include nonalcoholic fatty liver disease and post-transplant metabolic syndrome.  She engages in outcomes-based research with a special interest in NAFLD and liver transplantation: the post-transplant outcomes of patients with NAFLD, selection of patients with NAFLD for transplant, recurrence of NAFLD following transplant, and new-onset NAFLD after liver transplantation for other causes of liver disease

Dr. Brandman received her medical degree at UMDNJ New Jersey Medical School in 2005. She continued her medical training at University of California, San Francisco, where she completed her residency, gastroenterology fellowship, transplant hepatology fellowship, and master's degree in clinical research. Dr. Brandman is certified by the American Board of Internal Medicine in internal medicine and gastroenterology.  She is a member of the American Association for the Study of Liver Disease (AASLD).

  Award  
  Confired By    
  Date    
  • Resident Mentor of the Year
  • CTSI Resident Research Program
  • 2016
  • Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award
  • UCSF
  • 2015
  • Data provided by UCSF Profiles, powered by CTSI
    MOST RECENT PUBLICATIONS FROM A TOTAL OF 29
    Data provided by UCSF Profiles, powered by CTSI
    1. Brandman D. Jaundice in Polycystic Liver Disease: More Than Meets the Eye. Clin Liver Dis (Hoboken). 2021 Mar; 17(3):165-168. View in PubMed
    2. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. Am J Transplant. 2021 09; 21(9):3148-3156. View in PubMed
    3. Danielle Brandman. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clinics in Liver Disease. 2021 Feb 1; 25(1):1-18. View in PubMed
    4. Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. Disseminated Legionella micdadei infection in a liver transplant patient presenting as pulmonary nodules and a laryngeal lesion. Transpl Infect Dis. 2021 Jun; 23(3):e13563. View in PubMed
    5. Xu CQ, Zhou K, Brandman D. The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2021 Mar 01; 181(3):310-312. View in PubMed
    6. View All Publications

     

    Site Directory
      X